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Abstract A route of accumulation and elimination of
therapeutic engineered nanoparticles (NPs) may be the
kidney. Therefore, the interactions of different solid-
core inorganic NPs (titanium-, silica-, and iron oxide-
based NPs) were studied in vitro with the MDCK and
LLC-PK epithelial cells as representative cells of the
renal epithelia. Following cell exposure to the NPs,
observations include cytotoxicity for oleic acid-coated
iron oxide NPs, the production of reactive oxygen spe-
cies for titanium dioxide NPs, and cell depletion of
thiols for uncoated iron oxide NPs, whereas for silica
NPs an apparent rapid and short-lived increase of thiol
levels in both cell lines was observed. Following cell
exposure to metallic NPs, the expression of the tranfer-
rin receptor/CD71 was decreased in both cells by iron
oxide NPs, but only in MDCK cells by titanium dioxide
NPs. The tight association, then subsequent release of
NPs by MDCK and LLC-PK kidney epithelial cells,
showed that following exposure to the NPs, only
MDCK cells could release iron oxide NPs, whereas both
cells released titanium dioxide NPs. No transfer of any
solid-core NPs across the cell layers was observed.
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Introduction
Nanotechnology and the extended use of nanomaterials
in nanomedicine is a rapidly developing field. Since the
initial development of therapeutic nanoparticles (NPs),
the field of nanotechnology has gained a lot of interest
due to their huge potential for applications in industry
and medicine. Nevertheless, a deep understanding of
their interactions with living tissues and the knowledge
of their possible effects in the human (and animal) body
are necessary for the safe use of nanoparticulate formu-
lations. Therefore, it is mandatory to ensure and control
the biocompatibility of the components of therapeutic
NPs to ensure that their intrinsic toxicity does not over-
take their benefits. It is also necessary to understand
their distribution in the human body, their biodegrada-
tion, and their excretion routes. However, the knowledge
about possible interactions of engineered therapeutic
NPs with living cells and tissues is presently not com-
plete, and often the toxicological potential following
exposure and the metabolic fate of NPs in living tissues
and cells is not well defined (Caruthers et al. 2007; Heath
and Davis 2008; Singh 2010).
Therapeutic NPs reach the systemic circulation af-
ter inhalation, ingestion, or intravenous injection.
They may then disseminate to several organs, includ-
ing the kidneys, which have been postulated as the
probable final localizations and possible excretion
route of NPs in living organisms (Longmire et al.
2008, 2011; Tang et al. 2009; Semete et al. 2010;
Choi et al. 2011). The hypothesis of renal clearance
of NPs originates from the known functions of the
different tissue compartments of the kidney, and the
renal processing of molecules, including macromole-
cules, involves the glomeruli acting as blood filters
and the tubules which are able to transport solutes.
While the glomerular filtration of NPs has been ana-
lyzed in some detail, knowledge on the interactions of
NPs, in particular of metal-based solid-core NPs, with
the kidney epithelia is currently limited. However, this
knowledge is needed to gain information about the
renal toxicity profile of NPs. Accumulation of silver
or gold NPs in the glomeruli and in the basement
membranes of renal tubules after inhalation or inges-
tion has been shown (Kim et al. 2009; Choi et al.
2011). Evaluation of the interaction of titanium diox-
ide, silica, and iron oxide NPs, as well as other NPs,
with cells of the mesangium and proximal epithelium
of the kidney has shown the potential harmful role of
oxidative stress (L’Azou et al. 2008; Wang et al. 2009;
Pujalté et al. 2011; Mahmoudi et al. 2011; Passagne et
al. 2012). Thus, the evaluation of the effects of NP
exposure on the functions of kidney cells of various
subtypes, including of epithelial origin, needs further
consideration.
As not only the size but also the chemical composi-
tion, surface chemistry and charge, and shape determine
the behavior and clearance of NPs in a biological envi-
ronment, different types of NPs must be compared to
address these questions, in particular concerning NPs
which have the potential to be used as therapeutic and
diagnostic agents in nanomedicine. Ultrasmall super
paramagnetic iron oxide (USPIO) NPs were developed
for magnetic resonance imaging of the reticuloendothe-
lial system, such as the liver, spleen, and lymph nodes,
for perfusion imaging of the brain, myocardium, and
kidney and for angiography and tumor vascular imaging
and have been recently extended to new applications
(Wang et al. 2001; Wu et al. 2004; Alexiou et al. 2006;
Weinstein, et al. 2010). Fluorescent silica NPs have been
widely applied in nanobiotechnology as new fluorescent
nano-probes and biosensors, as drug delivery vehicles,
and were also reported to be efficient tumor cell imaging
agents (Wu et al. 2008; Lee et al. 2010; Liu et al. 2011).
The use of titanium dioxide NPs in sunscreens and
cosmetics has been extended to new applications in
tissue engineering and biomaterials using their anti-
bacterial properties for improving the properties of im-
plant coatings (Yuan et al. 2010; Rupp et al. 2010).
In the present study, we used two widely studied
epithelial kidney cell lines, the canine Madin Darby
canine kidney (MDCK) cells, as a model for the renal
distal tubular cells forming a very tight cellular barrier,
and the porcine LLC-PK cells which are derived from
the proximal tubule and form less tight epithelial cell
layers. These cells present with cell–cell junctions and
transport water, sodium, and calcium when seeded on
semi-permeable supports and in confluent cell cultures
form characteristic storage vesicles necessary for their
water transport functions (Kuniaki et al. 2004). The
interaction of selected inorganic solid-core (iron oxide-,
silica-, and titanium dioxide-based) NPs was studied
with these renal cells, determining their possible cyto-
toxicity, induction of an oxidative stress, and repression
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of the expression of the transferrin receptor and ques-
tioning the subsequent release as well as the transfer
across cell layers of the NPs by the kidney cells follow-
ing exposure.
Methods
Nanoparticles
Uncoated ultrasmall superparamagnetic iron oxide nano-
particles (Fe3O4, uncoated USPIO NPs) were obtained
from PlasmaChem (PlasmaChem GmbH Adlershof,
Germany) as a ~3 % nanosuspension in water, average
nanoparticle size 8±3 nm (as determined by dynamic
light scattering (DLS)), zeta potential +15 mV in 10 mM
NaCl, −23 mV in DMEM. The iron content was deter-
mined to be 18 mg iron/ml by quantitative Prussian Blue
reaction according to a previously described protocol
(Petri-Fink et al. 2005; Cengelli et al. 2010). Oleic acid-
coated USPIO NPs (Fe3O4, 3 % oleic acid coating) were
obtained from PlasmaChem as a ~7% nanosuspension in
water, average particle iron oxide core size 8±3 nm,
hydrodynamic size 14–15 nm (determined by DLS),
and zeta potential −30 mV at pH 7. The iron content
was determined to be 206 mg iron/ml by quantitative
Prussian Blue reaction. AminoPVA-coated USPIO NPs
were prepared and characterized according to the proto-
col previously described (Petri-Fink et al. 2005). Briefly,
ferrofluid was prepared by alkaline co-precipitation of
ferric and ferrous chlorides, refluxed in nitric oxide–
ferrous nitrate, and dialyzed, providing iron oxide nano-
particles (ferrofluid) of 9 nm. To obtain aminoPVA-
coated USPIO NPs, the ferrofluid was mixed with poly
(vinylalcohol, PVA), poly(vinylalcohol/vinylamine,
aminoPVA) at a polymer-to-iron ratio of 10 and a PVA-
to-aminoPVA copolymer ratio of 45 (mass ratios), result-
ing in aminoPVA-coated USPIO NPs of hydrodynamic
diameter of 25 to 30 nm and a positive zeta potential
of +25 mV. Titanium dioxide nanopowder (Aeroxide®
TiO2 P25) (TiO2 NPs) was obtained from Evonik
(Evonik Degussa GmbH, Hanau, Germany), average
particle size 21 nm, large dispersion size, zeta potential
−30 mV (Magdolenova et al. 2012). Fluorescent
rhodamine-labeled silica nanospheres (25 nmfl-silica
NPs and 50 nmfl-silica NPs) were obtained from
Corpuscular as a 25-mg/ml suspension in water
(Corpuscular, Inc, Cold Spring, USA) (17 and 12 mg/
ml, respectively, as measured by thermogravimetric
analysis by H Hofmann and P Bowen, LPT, EPFL), zeta
potential −40 mV. The primary characteristics of the NPs
have been previously published (Table 1 in Halamoda
Kenzaoui et al. (2012b); Halamoda Kenzaoui et al.
2012a, 2012c; Magdolenova et al. 2012).
Cell lines and culture conditions
Canine MDCK epithelial cells and porcine kidney
(LLC-PK) epithelial cells are available from the
American Type Culture Collection (Manassas, VA,
USA) and were grown in DMEM medium containing
4.5 g/l glucose, 10 % fetal calf serum, and penicillin/
streptomycin antibiotics. All cell culture reagents were
purchased from Gibco, Invitrogen, Basel, Switzerland.
Cells were exposed to NPs in 250 μl of complete
culture medium in 48-well plates (Costar, Corning,
NY, USA) at decreasing concentrations, from 235 to
0.4 μg/ml NPs. Experiments were performed in tripli-
cate wells at least twice in independent experiments.
Means ± standard deviations (sd) were calculated. The
interference of the NPs with the assays was evaluated
and results were corrected when required.
Cell exposure to, association with, and release
of USPIO NPs
Cells were grown in 48-well plates (Costar) until 75 %
confluent and then exposed to USPIO NPs for the
concentration and time indicated. The plates were
washed three times with saline and analyzed for iron.
Control cells without exposure to USPIO NPs were
treated in the same conditions. To quantify cellular
iron content, the cell layers were dissolved at room
temperature for 1 h in 6 N HCl (125 μl/well of a 48-
well plate); then, 125 μl of a 5 % solution of K4[Fe
(CN)6]·3H2O (Merck, VWR international, Nyon,
Switzerland) in H2O was added for 10 min and the
absorbance was measured at 690 nm in a multiwell plate
reader (iEMS Labsystems, BioConcepts, Allschwil,
Switzerland). A standard curve of FeCl3 in 6 N HCl
treated in the same conditions was used to quantify the
amount of cell-bound iron. For release measurements
following cell exposure to USPIO NPs, the cell layers
were washed three times with PBS; complete DMEM
mediumwithout phenol red (Gibco) and without USPIO
NPs was added to the cells for 24 h; then, 50 μl of
culture medium was retrieved and iron content in the
culture medium was analyzed. All experiments were
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performed in triplicate wells and repeated at least twice.
Means ± sd were calculated.
Histochemical determination of iron
After exposure to USPIO NPs, the cell layers were
washed with saline and incubated for 20 min at room
temperature with a 1:1 solution of 10 % HCl and 10 %
K4[Fe(CN)6]·3H2O in H2O, washed with distilled wa-
ter, counterstained with Nuclear Fast Red (Merck,
Darmstadt, Germany), dehydrated in graded ethanol
to xylol, and mounted. Slides were photographed under a
Nikon digital camera (DXM 1200, Nikon Corporation,
Tokyo, Japan).
Cell exposure to and release of TiO2 NPs
Cells were grown in 48-well plates (Costar) until 75 %
confluent and then exposed to increasing concentrations
of TiO2 NPs for 24 h. The cell layers were washed three
timeswith PBS; then, complete DMEMmediumwithout
phenol red (Gibco) and without NPs was added to the
cells. After 72 h of washout, 200 μl of cell culture
supernatant was retrieved and its absorbance at 540 nm
was determined in a multiwell plate reader (iEMS
Labsystems). All experiments were performed in tripli-
cate wells and repeated at least twice. Means ± sd were
calculated.
Cell exposure to, association with, and release
of fluorescent silica NPs
Cells were grown in 48-well plates (Costar) until 75 %
confluent and then exposed to silica NPs for the con-
centration and time indicated. Plates were washed
twice with PBS and the fluorescence was measured
in fresh PBS at lex/lem=530/620 nm in a thermostated
fluorescence plate reader (CytoFluor Series 4000,
PerSeptive Biosystems, MA, USA). For release studies,
the cells were incubated for another 24 h with fresh
complete DMEM medium without NPs and without
phenol red (Gibco); then, 200 μl of cell culture super-
natants was transferred to another plate and the fluores-
cence was measured.
Fluorescence microscopy
Cells were grown for 24 h on glass slides (four-cham-
ber Polystyrene Vessel Culture Slides, BD Falcon,
Erembodegem, Belgium). Then, the medium was re-
moved, and the silica NPs diluted in complete culture
medium were added at the desired concentrations for a
further 24 h. At the end of the exposure, the cell layers
were washed in PBS, fixed in 4 % buffered paraformal-
dehyde for 20 min at 4 °C, washed in PBS, and incu-
bated with 4′,6′-diamidino-2-phenylindole (DAPI)
(Roche-Diagnostics, Rotkreuz, Switzerland, 1 μg/ml in
PBS) for 30 min at 37 °C. The slides were washed with
PBS and mounted in 20 % glycerol (Invitrogen) in PBS
and then examined by fluorescence microscopy for
DAPI labeling (Zeiss Axioplan 2, filters: lex/lem=365/
420 nm) and rhodamine-labeled silica NPs (Zeiss
Axioplan 2, filters: lex/lem=530/620 nm).
Evaluation of cell viability
Cells were grown in 48-well cell culture plates (Costar)
until 75 % confluent and exposed to the NPs for the
concentration and time indicated; then, the cell layers
were washed in saline. Cell viability was evaluated
using the 3,4,5-dimethylthiazol-yl-2,5-diphenyl tetrazo-
lium bromide (MTT) assay (Sigma-Aldrich Buchs,
Switzerland) added to the cells in fresh complete culture
medium at 250 μg/ml final concentration for 2 h; then,
the precipitated formazan was dissolved in 0.1 N HCl in
2-propanol and quantified at 540 nm in a multiwell plate
reader (iEMS Labsystems). The interference of the NPs
with the assay was controlled. All experiments were
performed in triplicate wells and repeated at least twice.
Means ± sd were calculated.
Evaluation of DNA synthesis
Following cell exposure to the NPs for 48 h,
tritiated thymidine (3H-T) (Amersham-Pharmacia,
Glattbrugg, Switzerland, 400 nCi/mL final concen-
tration) was added to the cells for 2–4 h. Then,
the cell layers were precipitated with 10 % tri-
chloroacetic acid and dissolved in 0.1 % sodium
dodecyl sulfate (SDS) in 0.1 N NaOH, and scintillation
cocktail (Optiphase HI-Safe, PerkinElmer, Beaconsfield,
UK) was added. Radioactivity was counted with a β-
counter (WinSpectra, Wallac, Germany). The radioactiv-
ity counts of treated cells were compared to the radioac-
tivity counts of untreated cells. Experiments were
conducted in triplicate wells and repeated twice. The
interference of the NPs with the assay was controlled.
Means ± sd were calculated.
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Evaluation of ROS production
Free radical formation was determined with 5/6-car-
boxy-2,7-dichloro-dihydro-fluorescein (carboxy-
H2DCFDA). Cells were grown until confluent in 48
well-plates (Costar) and then preincubated for 40 min
with carboxy-H2DCFDA, (Molecular Probes,
Invitrogen Basel, Switzerland; stock solution 25 mg/
ml DMSO, final concentration 20 μM), washed, and
incubated at 37 °C with the NPs diluted in enriched
Hank’s buffer solution containing 1.3 mM Ca2+,
1.1 mMMg2+ and 5 mM glucose (HBSS; Gibco). t-
Butyl hydroperoxide (TBHP; Sigma-Aldrich, 5 mM)
was used as a positive control for free radical formation.
The plate was immediately read at lex/lem=485/530 nm
in a thermostated fluorescence plate reader (CytoFluor)
and then every hour for 4 h. All experiments were
performed in triplicate wells and repeated at least twice.
The interference of the NPs with the assay was con-
trolled. Means ± sd were calculated.
Determination of cellular thiols
The monobromobimane assay was used to measure
cellular thiol levels. Cells were grown until half-
confluent in 48-well plates (Costar), exposed for 4,
24, or 48 h to the NPs, and washed with HBSS; then,
250 μl/well of 100 μM monobromobimane (Sigma-
Aldrich) in HBSS was added at room temperature for
5 min in the dark. The cell layers were washed with
HBSS and lyzed with 0.1 % Triton X-100 (Sigma-
Aldrich) in HBBS. For a positive control for thiols
consumption, the cells were exposed to 100 μMN-
ethyl-maleimide (Sigma-Aldrich) for 1 min before
the assay. The fluorescence was immediately read in
a thermostated fluorescence plate reader (CytoFluor)
at lex/lem=485/580 nm. All experiments were per-
formed in triplicate wells and repeated at least twice.
The interference of the NPs with the assay was con-
trolled. Means ± sd were calculated.
Transwell cultures
MDCK or LLC-PK cells (5×104 or 8×104 cells/cm2,
respectively) were seeded in 0.5 ml of complete me-
dium in the apical upper compartment of Transwells®
inserts (Costar, polyester membrane, pore diameter
3 μm, 12 inserts par plate); then, 1.5 ml of complete
culture medium was added in the basal chamber. After
24, 48, 72, or 96 h of culture, the transepithelial electri-
cal resistance (TEER) of the cell layers was measured at
room temperature in complete culture medium with the
Millicell-ERS voltohmmeter (according to the protocol
of the provider, Millipore, MA, USA) in triplicates and
the results were averaged; then, the transport of Lucifer
Yellow (LY; see the following section) was performed at
37 °C to control for the increase in the cell layer tight-
ness. Cells on the Transwells were examined using
histological staining with methylene blue/azure and he-
matoxylin/eosin stains and immunocytochemical stain-
ing for occludin (see the following section). The
evaluation of the transport of the NPs was performed
after 72 h of culture when tightness was optimum.
Lucifer Yellow transfer
Both the apical and basal chambers of the Transwells
were washed twice with HBSS containing 1.3 mM
Ca2+ and 1.1 mMMg2+, pH 7.4, preheated at 37 °C.
LY (Sigma-Aldrich), final concentration 100 μM in
HBSS, was added to the apical chamber and the devi-
ces were incubated at 37 °C. After 30, 60, 90, and
120 min, 200 μl of the solution from the basal cham-
bers was removed and transferred into the wells of a
96-well plate for fluorescence reading and then
replaced into the basal chamber. Fluorescence was
determined in a thermostated fluorescence multiwell
plate reader (CytoFluor) at lex/lem=450/530 nm and
compared with a standard curve of LY in HBSS at 37 °C.
Immunofluorescence
To examine for the presence of tight junctions in the
cell layers, cells were grown for 72 h on Transwell
membranes, fixed in 4 % buffered paraformaldehyde
at 4 °C for 1 h, washed in PBS, permeabilized with
cold methanol for 10 min at 4 °C, and incubated with
5 % bovine serum albumin (BSA; Sigma-Aldrich)
in PBS for 1 h at room temperature. Antibody
staining was performed with the monoclonal anti-
occludin antibody conjugated to Alexa Fluor 488
(Molecular Probes, diluted 1:100 in 3 % BSA, 0.1 %
Tween-20 in PBS) and incubated overnight at 4 °C.
After washing in PBS, one drop of DAPI (Roche-
Diagnostics, 1 μg/ml) was added; the slides were
covered and sealed with nail polish and examined
by fluorescence microscopy (Zeiss Axioplan 2, filters:
lex/lem=365/420 nm).
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Transfer of NPs across renal cell layers
Both the apical chambers with kidney cells grown for
72 h and the basal chambers of the Transwells were
washed twice with DMEM medium without phenol
red (Gibco). Then, the apical chambers were filled
with USPIO NPs (100 μg iron/ml) or fluorescent silica
NPs (235 μg/ml) in DMEM without phenol red and
the basal chambers with DMEM without phenol red.
After 0, 2, 8, and 24 h of incubation, 50 μl of the
medium from the basal chambers was removed and
analyzed for iron oxide (Prussian Blue reaction) or
rhodamine-silica (fluorescence) NPs content. The
volume in the receiver chambers was maintained by
adding 50 μl of fresh medium after each sampling.
Parallel experiments were performed in the absence of
cells (empty membranes). At the end of the experiment,
the cells on the membrane inserts were washed three
times with saline, detached with trypsin-EDTA (Gibco),
centrifuged, and analyzed for iron content by the
Prussian Blue reaction. All experiments were performed
in triplicate wells and repeated at least twice, and
means ± sd were calculated. The fluorescence of the
silica NPs is not stable under the Transwell experimental
conditions for more than 6 h; thus, the silica NP content
of cells at the end of the experiments was not evaluated.
Transmission electron microscopy
MDCK and LLC-PK cells were grown on Transwell
filters until confluent and then exposed to the NPs for
the concentration and time indicated. At the end of the
incubation, the cells were washed twice with PBS,
fixed in 3 % glutaraldehyde in PBS (Sigma-Aldrich)
for 24 h, and washed in cacodylate buffer. Samples
were postfixed in 1.3 % osmium tetroxide in 0.2 M
cacodylate buffer, pH 7.4, for 1 h and dehydrated in
graded ethanol and then in propylene oxide and em-
bedded in 50 % (w/w) epoxy embedding medium,
26 % (w/w) dodecenylsuccinic anhydride, 23 % (w/w)
methyl nadic anhydride, 1 % (w/w) 2,4,6-tris(dimethy-
laminomethyl)phenol (DMP-30) (all from Fluka or
Sigma-Aldrich). Blocks were cured for 48 h at 60 °C;
thin sections (80–100 nm) were cut using an ultrami-
crotome (Ultracut E, Reichert-Jung Optische Werke
AG, Wien, Austria) and mounted on 3-mm 200-mesh
copper grids. Grids were stained for 75 min in saturated
uranyl acetate solution (Fluka) and then for 100 s in lead
citrate (Ultrostain 2, Laurylab, St Fons, France),
examined, and photographed with a Philips CM10
transmission electron microscope combined with a
MegaView III Soft Imaging system to document cell-
associated USPIO NPs.
Western blot experiments
Cells were grown in 9-cm diameter Petri dishes (BD-
Falcon) and exposed to the NPs (100 μg/ml, final con-
centration) for 24 h. Then, the cell layers were washed
with cold PBS and lysed in 200 μL of lysis buffer
(150 mM NaCl, 2 mM EDTA, 0.5 % Triton X-100,
50 mM Tris–HCl, 2 mM vanadate, 50 mM NaF, pH
7.2) and 10 μL of protease inhibitor cocktail (Sigma-
Aldrich), scraped with a cell scrapper, extracted by three
cycles of freeze/thawing and centrifuged at 10,000 rpm
at 4 °C for 10min. Supernatants were submitted to SDS-
PAGE and transferred onto a nitrocellulose membrane
(Whatman, Dassel, Germany). The membranes were
blocked with 5 % fat-free milk in PBS, washed
in 0.05 % Tween-20 (Sigma-Aldrich) in PBS, and
incubated overnight at 4 °C with the goat polyclonal
anti-transferrin receptor/CD71 antibody (Santa Cruz
Biotechnology, CA, USA; diluted 1:5,000) and then
exposed for 60 min to peroxidase-conjugated anti-goat
antibody (Sigma-Aldrich, diluted 1:10,000) and visual-
ized by chemiluminescence with the ECL detection kit
(Amersham International PLC, Buckinghamshire, UK).
To control for loading, the membranes were stripped by
successive incubation in 0.1 M glycine, pH 2.3, 1 M
NaCl in PBS, and 0.05% Tween-20 in PBS, blocked for
1 h with 5 % fat-free milk in PBS, and exposed to the
polyclonal anti-β-actin antibody (Sigma-Aldrich, dilut-
ed 1:5,000) for 1 h at room temperature followed by 1 h
of incubation with peroxidase-conjugated anti-rabbit
antibody (Promega, Wallisellen, Switzerland, diluted
1:20,000) and visualized by chemiluminescence (ECL,
GE Healthcare, Amersham, UK).
Results
Cytotoxicity of the NPs for MDCK and LLC-PK cells
The MTT assay which measures the mitochondrial
activity of viable cells was employed to evaluate the
cytotoxicity of the NPs for the two kidney epithelial
cell lines (Fig. 1). None of the tested NPs was highly
cytotoxic. Only oleic acid-coated USPIO NPs, and to a
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lesser extent TiO2 NPs, were cytotoxic at the highest
tested concentrations. Free oleic acid at concentrations
corresponding to oleic acid concentrations of USPIO
NPs was not cytotoxic for the cells (Fig. 1b).
The effect of cell exposure to the NPs on DNA
synthesis was also determined using the thymidine
incorporation assay (Fig. 2). Only oleic acid-coated
USPIO and 25 nm fluorescent silica NPs decreased
DNA synthesis in cells after 48 h of exposure. TiO2
NPs did not induce any change in DNA synthesis. The
LLC-PK cells were less sensitive than the MDCK
cells to the NP effects.
Generation of an oxidative stress in MDCK
and LLC-PK cells exposed to the NPs
The production of reactive oxygen species (ROS) in
exposed cells was determined first using carboxy-
dichloro-dihydro-fluorescein ester, which is internal-
ized by the cells and oxidized to the fluorescent car-
boxy fluorescein by hydrogen peroxide and other ROS
present in the cells. MDCK and LLC-PK cells pro-
duced only low amounts of ROS even when stimulat-
ed with TBHP as a positive control. Titanium dioxide
NPs were the only NPs tested to induce the production
of ROS in exposed MDCK and LLC-PK cells in
amounts even higher than the levels resulting from
treatment with TBHP (Fig. 3a).
After 24 or 48 h of exposure of the cells to the NPs,
the cell content in cellular thiols, which are consumed
during oxidative stress of cells, was also determined
using the bromobimane assay. Uncoated USPIO NPs
induced a significant decrease of cellular thiol content
in MDCK cells and LLCPK cells after 24 and 48 h of
exposure (Fig. 3b). Interestingly, both-sized fluores-
cent silica NPs induced an apparent rapid increase of
thiol levels in both cell lines after 24 h of exposure and
a decrease after 48 h of exposure, but only in LLC-PK
cells (Fig. 3c; 25 nm fluorescent silica NPs, data for
50 nm fluorescent silica NPs not shown). Treatment of
the cells with N-ethyl-maleimide was used as a posi-
tive control for thiol depletion in the cells.
Kidney cell association with and release of the NPs
First, the tight association of uncoated, oleic acid-
coated, or aminoPVA-coated USPIO NPs with
MDCK and LLC-PK cells was studied. Uncoated
USPIO NPs agglomerated immediately in the cell
culture medium, as previously reported (Halamoda
Kenzaoui et al. 2012a, b, c), and the agglomerates
precipitated on the bottom of the wells on the cell
layers, enhancing direct contact between the cells
and the NPs. Both aminoPVA-coated and oleic acid-
coated USPIO NPs were stable in the cell culture
medium and did not agglomerate during the experi-
mental time frame exposure. The cell-associated iron
content of USPIO NPs was determined using the his-
tological Prussian Blue reaction (Fig. 4a). The cell-
associated iron levels of the USPION NPs, as deter-
mined by quantitative Prussian Blue assay, increased
time- and cell line-dependently and was proportional
to the amount of NPs added (Fig. 4b). Oleic acid-
coated USPIO NPs associated only poorly with
MDCK and LLC-PK cells and the level of iron in
the cell layers after 24 h of exposure was under the
detection limit for quantitative measurement (data not
shown). The tight association of aminoPVA-coated
USPIO NPs was low after 4 h of exposure but in-
creased significantly after 24 h of exposure to high
concentrations (100 μg/ml and higher) of these NPs,
particularly in MDCK cells (Fig. 4b).
Then, the release of iron following exposure to
uncoated or aminoPVA-coated USPIO NPs by the
kidney cells following cell exposure to the NPs was
determined. In cells exposed to uncoated USPIO NPs,
the release of iron by the cells was determined after a
24-h washout period following uptake (Fig. 5). A
significant release of iron by MDCK cells but not by
LLC-PK cells was observed (Fig. 5a, gray bars). The
cell layers were also examined after the release exper-
iment for the presence of iron and, whereas in the
LLC-PK cell layers exposed to USPIO NPs iron was
still present proportionally to the exposure NP con-
centrations, no detectable amounts of iron were found
in the MDCK cell layers (Fig. 5a, black bars). The
release of iron by MDCK and LLC-PK cells exposed
to aminoPVA-coated USPIO NPs was not observed
even with the highest concentrations of exposure
(Fig. 5b).
The tight association of fluorescent 25 and 50 nm
silica NPs with the cells was analyzed by fluorescence
Fig. 1 Cytotoxicity of NPs for MDCK and LLC-PK cells.
Cytotoxicity for MDCK (left) and LLC-PK (right) cells of oleic
acid-coated USPIO NPs (a), 25 and 50 nm (c), and TiO2 NPs (d)
NPs was assessed after 72 h of exposure using MTT assay. The
cytotoxicity of free oleic acid at concentrations similar to its
concentration in the oleic acid-coated USPIO NPs was also
determined (b)

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microscopy (Fig. 6a) and quantified as cell-associated
fluorescence (Fig. 6b). With both techniques, the tight
association of 25 nm silica NPs was detected only at
the highest concentration tested (235 μg/ml), whereas
for 50 nm silica NPs it was under the detection limits
(data not shown). The release of 25 nm fluorescent
silica NPs following exposure of MDCK or LLC-PK
cells was not observed even at the highest exposure
concentrations.
The quantification of tight association of TiO2 NPs
with the kidney cells was technically not possible.
Following cell exposure to TiO2 NPs, the release into
the cell culture supernatants of light-absorbing par-
ticles was measured at 540 nm by turbidimetric
MDCK cells LLC-PK cellsA
B
C
Fig. 2 Effect of NPs on DNA synthesis by MDCK and LLC-
PK cells. DNA synthesis by MDCK (left) and LLC-PK (right)
cells exposed either to oleic acid-coated USPIO NPs (a), 25 nm
and 50 nm (b), or TiO2 NPs (c) NPs was assessed after 48 h of
exposure of the cells to the NPs
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MDCK cells LLC-PK cellsA
B
C
Fig. 3 Oxidative stress induced by the NPs in MDCK and
LLC-PK cells. a The production of ROS in NP-exposed MDCK
(left) and LLC-PK (right) cells was determined with the carbox-
yH2DCFDA assay performed after 4 h of exposure of the cells
to TiO2 NPs. Treatment of cells with tert-butyl-hydroperoxide
(TBHP) was used as a positive control. b, c Thiol levels were
quantified using the bromobimane assay in MDCK cells (left)
and LLC-PK cells (right) exposed to uncoated USPIO NPs (b)
or to 25 nm silica NPs (c) for either 24 h (gray bars) or 48 h
(black bars). Treatment of cells with N-ethyl-maleimide (NEM)
was performed to deplete cells of thiols
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Fig. 4 Tight association of USPIO NPs with MDCK and LLC-
PK cells. a The uptake of uncoated, oleic acid-coated, or
aminoPVA-coated USPIO NPs (20 μg iron/ml) by MDCK (left)
and LLC-PK (right) cells was visualized with the histological
Prussian Blue and Nuclear Red staining (nuclei and cytoplasm:
pink, iron: blue) after 24 h of exposure. b, c The uptake of
uncoated USPIO NPs (b) and aminoPVA-coated USPIO NPs (c)
by MDCK (left) and LLC-PK (right) cells was quantified with
the Prussian Blue reaction after 4 and 24 h of exposure
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spectrophotometry. The cells did not release particles
after 24 h of washout (results not shown); however,
after 72 h, the release of particles by MDCK cells and
LLC-PK cells was observed (Fig. 7).
Transfer of USPIO NPs across kidney cell layers
In order to evaluate if NPs can be transferred across
monolayers of kidney cells, MDCK and LLC-PK cells
were seeded on polyesther Transwell inserts; then, the
confluence and permeability of the cell layers were
examined after 24, 48, 72, and 96 h by hematoxylin/
eosin histological staining of the cell layers on the
membrane (Fig. S1a of the “Electronic supplementary
material”). The permeability of the cell layers was
examined by measuring the impairment of transfer of
LY across the cell layers (Fig. S1b of the “Electronic
supplementary material”), which was comparable in
both cell lines, as well as the TEER (Fig. S1c of the
“Electronic supplementary material”). TEER values
for MDCK cell layers was ≥1,500 Ω cm2 at 96 h
post-seeding, as expected for the known properties of
these cells to form very tight junctions and much
higher than the electrical resistances of LLC-PK cells
(~200 Ω cm2). The presence of occludin, which is a
protein participating in the formation of tight junctions,
was observed in MDCK and LLC-PK cell layer at 72 h
post-seeding (Fig. S1e of the “Electronic supplementary
material”). As examined on transverse methylene blue/
azure-stained histological slides of the cells on the
Transwell membranes, MDCK cells formed a thick
and tight cell layer, with several cells migrating across
the pores toward the other side of the membrane, where-
as the LLC-PK cell layer was thin, flat, less compact,
and with only few cells migrating through the mem-
brane (Fig. S1d of the “Electronic supplementary mate-
rial”). The presence of junctions between the cells was
demonstrated by transmission electron microscopy
(TEM) at 72 h post-seeding (Fig. S2 of the “Electronic
supplementary material”). MDCK cells formed tight
junctions, visible especially at the top of the cell layer,
whereas desmosomes were frequently present in both
MDCK cells LLC-PK cellsA
B
Fig. 5 Release of USPIO
NPs by MDCK and LLCPK
cells following exposure. a
MDCK (left) and LLC-PK
(right) cells were exposed to
uncoated USPIO NPs for
24 h, washed with PBS, then
incubated with fresh medi-
um for another 24 h, and the
iron concentration was
quantified in the cell culture
supernatants (light gray
bars) and in the cell layer
(black bars) with the Prus-
sian Blue reaction. bMDCK
(light gray bars) or LLC-PK
(dark bars) cells were ex-
posed to aminoPVA-coated
USPIO NPs for 24 h,
washed with PBS, then in-
cubated with fresh medium
for another 24 h, and the
iron concentration was
quantified in the cell culture
supernatants with the
Prussian Blue reaction
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cell lines. Thus, under our experimental conditions, these
cells are representative of their expected epithelial func-
tions in the kidney, and the interval between 72 and 96 h
was chosen as optimal for performing the transfer experi-
ments across confluent cell layers. The transfer of both
oleic acid- and aminoPVA-coated USPIONPs, which do
not agglomerate under the experimental conditions, was
studied during a 24-h time course (Fig. 8a). Neither oleic
acid- nor aminoPVA-coated USPIO NPs were trans-
ferred across the renal cell layers, whereas both USPIO
NPs were able to pass across the empty Transwell mem-
branes. The iron content of the cell layers quantified at
the end of the experiment (Fig. 8a, intracel) was low in
MDCK cells exposed to oleic acid-coated USPIO NPs
and higher in cells exposed to aminoPVA-coated USPIO
NPs, whereas it was comparable in LLC-PK cells ex-
posed to both USPIO NPs. TEM images of cells on the
membranes after the transfer studies confirmed this in-
formation. MDCK cells demonstrated a tendency to
migrate across the pores of the membrane; these migrat-
ing filipodia still loaded with NPs were visible in cell
vacuoles of the migrating cells (Fig. 8b, right). The
transfer by MDCK and LLC-PK cells of 25 and 50 nm
fluorescent silica NPs was also investigated in two dif-
ferent media, DMEM or Ca/Mg-supplemented HBSS.
We observed that under the Transwell experimental
Fig. 7 Release of light-absorbing particles by MDCK and LLC-
PK cells exposed to TiO2 NPs. The release of particles by
MDCK (gray bars) and LLC-PK (black bars) cells exposed to
TiO2 NPs for 24 h, then washed, and incubated with fresh
medium for another 72 h was measured in the culture super-
natants by turbidimetry
A MDCK cells LLC-PK cells
B
20 µm 20 µm
Fig. 6 Association and
release of fluorescent silica
NPs by MDCK and LLCPK
cells. a Cellular uptake of
25 nm fluorescent silica NPs
(200 μg/ml NPs) by MDCK
(left) and LLC-PK (right)
cells was determined after
24 h of exposure by fluo-
rescence microscopy in cells
stained with DAPI (nuclei
fluoresce blue, rhodamine-
labeled silica NPs fluoresce
red). b Uptake by MDCK
and LLC-PK cells of 25 nm
silica NPs was quantified by
cell-associated fluorescence
(black bars) after 24 h of
exposure. Then, the cells
were incubated with fresh
medium for another 24 h
period and the fluorescence
of NPs-associated rhoda-
mine was quantified in the
supernatant (gray bars)
52 Cell Biol Toxicol (2013) 29:39–58
setting, but not under standard cell culture conditions,
the fluorescent labeling of the NPs was not stable in both
media and decreased rapidly after 6 h, limiting the time
course of the transfer experiment to 6 h. Fluorescent
25 nm silica NPs crossed the empty Transwell mem-
brane more efficiently than the 50 nmNPs; nevertheless,
none of the silica NPs was transferred across confluent
MDCK or LLC-PK cell layers for up to 6 h (Fig. 9a).
The internalization of 25 nm fluorescent silica NPs by
the cells on the Transwell membrane was confirmed by
TEM (Fig. 9b).
Expression of the transferrin receptor by kidney cells
exposed to iron oxide and titanium dioxide NPs
We have previously shown that the expression of the
transferrin receptor/CD71, which contains an iron-
responsive element in its promoter, is down-regulated
when human cells are exposed to either aminoPVA-
coated or uncoated USPIO NPs (Cengelli et al. 2010;
Halamoda Kenzaoui et al. 2012b). Thus, we evaluated
whether USPIO NPs as well as TiO2 NPs, representing
different solid-core metallic NPs compared to USPIO
NPs, may have similar cellular consequences on this
membrane iron transporter in kidney epithelial cells.
The expression of the transferrin receptor/CD71 was
determined by western blot in MDCK and LLC-PK
cells exposed to either uncoated USPIO NPs or TiO2
NPs (Fig. 10), two agglomerating NPs under the cell
culture conditions. The results demonstrated that in
MDCK cells the expression of the transferrin recep-
tor/CD71 was down-regulated not only by the USPIO
NPs but also by TiO2 NPs, however at a lesser extent
than iron oxide NPs. In LLC-PK cells, only USPIO
NPs down-regulated the expression of the transferrin
receptor/CD71. The results are summarized in Table 1.
oleic acid-coated USPIO NPs aminoPVA-coated USPIO NPsA
B
LLC-PK cells MDCK cells
1 µm
Fig. 8 Transfer of oleic acid-coated and aminoPVA-coated
USPIO NPs across MDCK and LLC-PK cell layers. a Transfer
of oleic acid-coated (left) and aminoPVA (right) USPIO NPs
across confluent MDCK (gray bars) and LLCPK (white bars)
cell layers and across the empty membranes (black bars). The
iron content of the MDCK (gray bars, intracel) and LLC-PK
(white bars, intracel) cell layers after the transfer study was also
determined. The initial applied concentration of iron in the
apical chamber was 100 μg/ml (50 μg of iron per Transwell),
and the iron amount in the basal chamber was measured using
the Prussian blue reaction. b TEM images of LLC-PK cells
exposed to oleic acid-coated USPIO NPs (left) and MDCK cells
exposed to aminoPVA USPIO NPs (right) for 24 h on the
Transwell membrane. M membrane, P membrane pore, black
arrow NPs
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Discussion
The use of engineered nanoparticles in the industry
and medicine has significantly increased, thus the
potential for human exposure. This may pose a health
concern since it has been shown in vitro and in vivo
that NPs can induce adverse effects to cells and tissues
(Wang et al. 2007; Napierska et al. 2009; Naqvi et al.
2010). It has to be emphasized that in vitro studies are
necessary in the biological assessment of NPs so as to
provide information concerning fundamental knowl-
edge on biological targets and effects. However, the
extrapolation of in vitro data for assessment of NPs
needs to take into account the lack of knowledge on
the uptake and distribution of NPs in organs in vivo. In
vivo studies have shown that from the blood circula-
tion, depending on their bio-physico-chemical proper-
ties, NPs can reach and accumulate in different organs
such as the liver, spleen, kidneys, heart, or lungs (Jain
et al. 2008; Tang et al. 2009; Semete et al. 2010).
Kidney is particularly susceptible to xenobiotics, ow-
ing not only to its high blood supply but also to its
ability to concentrate them for elimination. However,
up to now, the impact of solid-core NPs for kidney
epithelial cells has received little attention, and the
Fig. 9 Transfer of fluores-
cent silica NPs by MDCK
and LLC-PK cells. a Transfer
of fluorescent 25 nm silica
NPs across MDCK (black
diamonds) and LLC-PK
(open squares) cell layers
and in the absence of cells
(black triangles). The initial
concentration of silica NPs in
the apical chamber was
235 μg/ml (117.5 μg NPs
per Transwell), and the ex-
periment was performed in
HBSS buffer. b TEM images
of LLC-PK cells exposed
for 6 h to fluorescent 25 nm
silica NPs on the Transwell
membrane. M membrane,
P membrane pore, black
arrow silica NPs, white ar-
row cell fragments passing
through the membrane
pores
Fig. 10 Expression of the transferrin receptor/CD71 by MDCK
and LLC-PK cells exposed to uncoated USPIO and TiO2 NPs.
Cells were exposed to 100 μg/ml2 NPs for 24 h; then, the
expression of the transferrin receptor/CD71 and of β-actin as a
loading control was determined by Western blotting in cell
extracts
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evaluation of NP effects on renal cells have only few
reported precedents. Some in vivo experiments
evidenced kidney damage, associated with morpho-
logical, pathological, and cellular changes leading to
kidney dysfunction after exposure to NPs (Chen et al.
2006; Wang et al. 2007), while no pathological
changes were found in rat kidneys after an intravenous
administration of iron oxide magnetic NPs (Jain et al.
2008). The NP size-dependent cytotoxicity and oxida-
tive stress generation induced by carbon nanotubes,
titanium dioxide, and other metallic NPs in renal cells
have also been assessed in vitro (L’Azou et al. 2008;
Pujalté et al. 2011; Passagne et al. 2012). Increased
levels of ROS production and some cytotoxicity were
also observed in human embryonic kidney cells or
proximal tubular cells exposed to silica NPs (Wang
et al. 2009; Pujalté et al. 2011; Passagne et al. 2012),
which might be inversely proportional to the size of
silica NPs (Passagne et al. 2012). Cytoskeleton dis-
ruption and autophagy induction in LLC-PK renal
cells by fullerenol NPs and quantum dots were
reported (Stern et al. 2008; Johnson-Lyles et al. 2010).
To study the impact of engineered NPs in renal
cells, we selected two epithelial kidney cell lines
widely used for in vitro studies, originating either from
the proximal (LLC-PK cells) or the distal (MDCK
cells) tubules. We evaluated and compared their re-
sponse to exposure to different types of inorganic
solid-core NPs of interest for biomedical applications,
titanium dioxide, two-sized silica NPs, and iron oxide
(USPIO) NPs, either uncoated or coated with oleic
acid or with aminoPVA. Except for uncoated USPIO
NPs and TiO2 NPs which agglomerated immediately
and sedimented in the wells on the cell layers, the
tested NPs were stable colloids in cell culture medium.
The fluorescent 25 nm silica NPs associated with the
cells at higher levels than the fluorescent 50 nm silica
NPs, but none of these NPs was subsequently released
by or transferred across the cells. Among the three
USPIO NPs tested, the agglomerated uncoated USPIO
NPs tightly associated with the cells more efficiently
than the two coated USPIO NPs and, interestingly, they
were subsequently released by MDCK cells, but not by
LLC-PK cells. In these latter cells, the iron cores of the
USPIO NPs were still cell-associated at 48 h post-
exposure. On the contrary, both cells were able to re-
lease TiO2 NPs following exposure. When seeded on
semi-permeable membranes, MDCK cells formed a
very tight and impermeable cell barrier, while the
LLC-PK cell layer was less tight, these two cell lines
together representing two different renal barrier models
representative of their tissue of origin, the distal and the
proximal tubules, respectively. However, whatever the
model used, none of the NPs tested was able to cross
these renal barrier models at a level sufficient to be
detectable by the methods used. Nevertheless, the cells
themselves were able to migrate across the pores of the
membrane transporting the NPs with them.
We have previously shown, using human melanoma
and brain endothelial cells (Cengelli et al. 2010;
Halamoda Kenzaoui et al. 2012b), that USPIO NPs
repress the expression of the transferrin receptor/CD71,
a cell membrane protein involved in the import of iron
into cells. The repression of the transferrin receptor/
CD71 by uncoated USPIO NPs and TiO2 NPs was
observed only in MDCK cells, whereas in LLC-PK cells
only uncoated USPIO NPs repressed this expression.
Thus, not only the bio-physico-chemical properties of
the NPs but also the characteristics of the epithelial cells
are important for the cell responses to NP exposure.
These results also suggest that repression of the transfer-
rin receptor by metallic NPs is not restricted to iron-
based NPs but may be possibly dependent on the cellular
trafficking of the NPs. However, the repression of this
transporter seems to be a general response to iron-based
NPs in exposed cells, independent of the histological
origin of the cells.
The cytotoxicity of the NPs was assessed with the
MTT assay, reflecting the mitochondrial function in ex-
posed cells, and DNA synthesis, reflecting the prolifera-
tive potential of the cells. Oleic acid-coated USPIO NPs,
even if only poorly internalized by cells, were the most
cytotoxic among the NPs tested, though not associated
with the presence of free oleic acid potentially dissociat-
ing from the NPs. TiO2 NPs also demonstrated some
cytotoxicity in MDCK cells after long-term exposure.
However, cytotoxicity for all NPs was observed only at
the highest concentrations tested. The generation of ROS
by NPs is generally considered to be a major contributor
to NP cytotoxicity. ROS formation, when it exceeds the
cellular antioxidant defensive capacity, representedmain-
ly by cellular thiols such as glutathione, an essential
antioxidant of cells (Gomes et al. 2005; Marquis et al.
2009), induces oxidative damage to biomolecules, in-
cluding lipids, proteins, and DNA, ultimately leading to
cell death. Oxidative stress can be monitored using
dichlorofluorescein, detectingmostly hydrogen peroxide,
and by monobromobimane, measuring the intracellular
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level of thiols. In our study, only exposure to TiO2 NPs
induced elevated ROS production in both kidney cell
lines without decreasing intracellular thiol levels, sug-
gesting that the antioxidant adaptive cell response was
not thiol-mediated. However, decreased cellular thiol
levels were observed after exposure of the cells to un-
coated USPIO NPs and 25 nm silica NPs, the NPs that
were also able to decrease DNA synthesis in exposed
cells, but which did not induce high oxidative stress.
Thus, no direct relationship between oxidative stress
response of the cells and cytotoxicity was observed. It
has to be emphasized that MDCK cells were generally
more sensitive to the effect of NPs than LLC-PK cells,
providing a more sensitive model for evaluating the
interactions of kidney epithelial cells with NPs. Using
different kidney cells, from mesangial and proximal ep-
ithelial tubular origin, and titanium-, zinc-, or cadmium-
based NPs, it was shown that aggregating ZnO and CdS
NPs were cytotoxic and induced oxidative stress, result-
ing in GSH consumption, possibly mediated by NFκB
nuclear translocation (Pujalté et al. 2011). Aggregating
TiO2 NPs were not cytotoxic, induced a low oxidative
stress, and did not decrease GSH levels, confirming our
results. As for our observations, the effects were cell
dependent.
In conclusion, we have shown that inorganic solid-
core NPs with a therapeutic interest (titanium dioxide
NPs, silica NPs, iron oxide NPs) tightly associated with
and were internalized by MDCK and LLC-PK kidney
epithelial cells depending on the bio-physico-chemical
characteristics of their coating and size, showing that (1)
the size of NPs is important for interaction with the
kidney epithelial cells, (2) the chemical composition of
the solid core, metallic versus non-metallic, is also an
important factor, (3) the potential for their dissolution in
cells andmodification of the oxidative state of the cells is
a relevant issue, (4) the characteristics of the coating are
also important, not only as ensuing stability versus ag-
glomeration of the NPs but also most likely by modify-
ing the corona of the NPs, and (5) the cell association/cell
release of the NPs, very likely by regulating the amount
of cell-associated components of the NPs, plays a fun-
damental role in the stress reaction of kidney epithelial
cells to solid-core inorganic NPs. Following exposure,
MDCK cells were able to release uncoated iron oxide
and titanium dioxide NPs, but not aminoPVA-coated
NPs or fluorescent silica NPs, two NPs tightly associated
with the cells, whereas LLC-PK cells released exclusive-
ly titanium dioxide NPs following exposure. Even if
some of the NPs were internalized by the cells, none of
them was transferred as free NPs across either very tight
(MDCK cells) or less tight (LLC-PK cells) kidney epi-
thelial cellular barrier models. Nevertheless, we ob-
served that both cells were able to migrate across semi-
permeable membranes, transporting the NPs with them.
The NPs were generally cytotoxic only at high concen-
trations, and only titanium dioxide NPs were able to
generate oxidative stress, while iron oxide-based NPs
depleted the cells of the antioxidative thiols, without
measurable oxidative stress. The expression of the trans-
ferrin receptor/CD71, which contains an iron-responsive
element in its promoter, is down-regulated when the iron
content of cells increases. We had previously shown that
the expression of the transferrin receptor/CD71 de-
creased, whereas lysosomal enzyme activation increased
in cells exposed to USPIO NPs (Cengelli et al. 2010;
Halamoda Kenzaoui et al. 2012c), suggesting that the
iron oxide core of the USPIO NPs dissolved in the
lysosomes of the cells and diffused out of these organ-
elles to the nucleus. Similar results were observed in
MDCK and LLC-PK cells with uncoated iron oxide
NPs. In MDCK cells, but not in LLC-PK cells, however,
titanium dioxideNPs also repressed the expression of the
transferrin receptor/CD71, suggesting similar cell-
specific repressive effects for these metallic NPs.
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